Medical Research News

RSS

COVID boosters hinder SARS-CoV-2 Omicron

A new preprint research paper reports on the state of current knowledge as to the immune evasion capability of this variant, linking it to the type of vaccine used and the vaccination protocol.

6 Jan 2022

SARS-CoV-2 appears to persist in organs throughout the body for months

The coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), leads to asymptomatic or mild symptoms in most cases. However, in a significant minority, it causes moderate or severe disease, with lung damage and sometimes multi-organ dysfunction, the origin of which is currently a matter of intense debate.

6 Jan 2022

Study examines if antidepressants can benefit patients with osteoarthritis

A clinical trial published in Arthritis & Rheumatology recently examined whether duloxetine, a medication that is prescribed to treat depression and may also reduce chronic pain, can benefit patients with hip or knee osteoarthritis.

6 Jan 2022

How diet, supplements and lifestyle changes can help battle COVID

A recent editorial in the journal Nutrients emphasizes how efficacious non-pharmacological interventions in conjunction with the promotion of healthy lifestyle and dietary patterns may improve overall health status and reduce the risk of infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as well as the potential adverse effects of coronavirus disease 2019 (COVID-19).

6 Jan 2022

Researchers set out to determine the brain and gravity’s effect on eyesight

Colonizing Mars is no longer solely the work of science fiction but a potential future option for people who desire to live among the weightless. For headline grabbers like Jeff Bezos, NASA and Elon Musk, space colonization - or space settlement, a preferred term recommended by Bill Nye - is a big goal for the 21st century.

6 Jan 2022

New engineered nanomaterials help capture chemotherapy drugs to avoid tissue damage

Standard chemotherapies may efficiently kill cancer cells, but they also pose significant risks to healthy cells, resulting in secondary illness and a diminished quality of life for patients. To prevent the previously unavoidable damage, researchers, led by Penn State, have developed a new class of nanomaterials engineered to capture chemotherapy drugs before they interact with healthy tissue.

6 Jan 2022

Neural connections of newborns with brain injuries impact childhood functional outcomes

A new UCSF study that mapped the neural connections of newborns with two different kinds of brain injuries found the maps looked very different - and were linked to significantly different developmental outcomes years later.

6 Jan 2022

Mental health conservatorships led to lengthy inpatient stays among homeless people with mental illness

At a time when public and private agencies and the legal system are grappling with how to best assist people who live at the intersection of homelessness and mental illness during a global pandemic, UCLA researchers have found mental health conservatorships for people with disabling, severe mental illness who are also homeless can result in lengthy psychiatric hospitalizations.

6 Jan 2022

LIVE-AIR trial demonstrates efficacy of Lenzilumab for treatment of COVID patients with decreased oxygen saturation

The LIVE-AIR phase 3 clinical trial is associated with early treatment of hyperinflammatory response with the humanized monoclonal antibody lenzilumab in COVID-19 patients with decreased oxygen saturation. The study results are posted to the medRxiv* preprint server.

6 Jan 2022

New method to estimate how individual mutations affect transmission of SARS-CoV-2

A new study, posted to the medRxiv* preprint server, constructs an analytical SIR-based epidemiological model to analyze the effects of mutations on SARS-CoV-2 transmission from genomic surveillance data.

5 Jan 2022

After SARS-CoV-2 booster dose memory B cells adapt to Omicron

Memory B cells never forget recurrent viral exposures and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is no exception, according to a new medRxiv* preprint study.

5 Jan 2022

Addition of wound care nurse to prone-positioning team reduces the odds of pressure injuries in patients

The addition of a certified wound and skin care nurse to a multiprofessional prone-positioning team at Penn Medicine Princeton Health significantly reduced the odds of patients with COVID-19 developing pressure injuries, according to a study published in American Journal of Critical Care.

5 Jan 2022

Medical Research News

COVID boosters hinder SARS-CoV-2 Omicron

SARS-CoV-2 appears to persist in organs throughout the body for months

Study examines if antidepressants can benefit patients with osteoarthritis

How diet, supplements and lifestyle changes can help battle COVID

Researchers set out to determine the brain and gravity’s effect on eyesight

New engineered nanomaterials help capture chemotherapy drugs to avoid tissue damage

Neural connections of newborns with brain injuries impact childhood functional outcomes

Mental health conservatorships led to lengthy inpatient stays among homeless people with mental illness

LIVE-AIR trial demonstrates efficacy of Lenzilumab for treatment of COVID patients with decreased oxygen saturation

New method to estimate how individual mutations affect transmission of SARS-CoV-2

After SARS-CoV-2 booster dose memory B cells adapt to Omicron

Addition of wound care nurse to prone-positioning team reduces the odds of pressure injuries in patients

Study estimates the burden of pediatric asthma cases caused by traffic- related air pollution

Change in glutathione reductase lowers inflammation in present-day humans

Scientists estimate transmission advantage of Omicron over Delta variant as +105%

A new model for predicting COVID-19 severity at diagnosis

Booster dose elicits cross-reactive humoral immunity against SARS-CoV-2 Delta and Omicron variants

Analyzing cell-free RNA could reliably predict preeclampsia

Monoclonal antibody treatment of COVID-19 reduces viral shedding

First-responder cells launching the repair after heart attack promote inflammation overdrive

Membrane proteins in focus: Turning high-risk targets into routine workflows

How metabolic phenotyping can detect viral infections in minutes

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Latest News